Related Experiment Video

Updated: May 26, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

[Relapsing polychondritis: clinical and therapeutic analysis of 15 Mexican cases]

Hernando Cervera-Castillo1, Juan Carlos Cajigas-Melgoza, Lucío Ventura-Ríos

  • 1Hospital General Regional, Distrito Federal, Instituto Mexicano del Seguro Social, Mexico. cerverach@aol.com

Revista Medica Del Instituto Mexicano Del Seguro Social
|December 20, 2011
PubMed
Abstract

Insights

Relapsing polychondritis (RP) is a rare multisystem disease. This study analyzed fifteen cases, highlighting common symptoms like auricular chondritis and serious respiratory complications, emphasizing the need for specialized medical care.

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Context:

  • Relapsing polychondritis (RP) is a rare, multisystemic autoimmune disorder of unknown etiology.
  • Characterized by recurrent inflammation and cartilage destruction, RP affects multiple organ systems.
  • Fifteen cases diagnosed via Damiani criteria in Mexico were analyzed for clinical and therapeutic insights.

Purpose:

  • To present a clinical and therapeutic analysis of fifteen relapsing polychondritis cases.
  • To document the diverse clinical manifestations, treatment strategies, and outcomes in RP patients.
  • To underscore the complexity and specialized care requirements for managing relapsing polychondritis.

Summary:

  • The study included nine males and six females with a mean age of 52.4 years, averaging 86.7 months of disease duration.
  • Predominant manifestations included auricular chondritis (83%), dysphonia (66%), arthritis (60%), and ocular involvement (53%).
  • Treatments comprised corticosteroids (93%), methotrexate (60%), NSAIDs (46%), immunosuppressants (46%), and biologics (two cases). Significant complications included hoarseness, tracheal stenosis, and hearing loss, with five deaths attributed to respiratory failure, renal failure, or stroke.

Impact:

  • This case series highlights the multisystemic nature and severe respiratory complications associated with relapsing polychondritis.
  • Findings emphasize the critical need for highly specialized medical approaches in diagnosing and treating RP.
  • The study contributes to understanding the clinical spectrum and therapeutic challenges of this rare disease.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...